Sharepoint Solutions
PRODUCTS
-
With all the environmental challenges facing us today, doing everything we can to conserve and preserve our water is imperative. As you know, tens of thousands of leaks go undetected, equating to a staggering 6 billion gallons of water loss daily in the United States. To help combat this water loss, we have developed a program that provides you with the tools and knowledge to help find those undetected leaks. Our program is Leak Detection Pilot Program, and we want to partner with you.
-
Co-invented by Applied StemCell’s President and Chief Scientific Officer, Ruby Tsai, Ph.D., and Head of R&D, Alfonso Farruggio, Ph.D., TARGATT™ large knock-in technology enables rapid, efficient, and precise integration of large DNA fragments—up to 20 kb in a single reaction, more in nested reactions—into a specific intergenic locus.
-
ProPharma has built the world’s leading and first full-service global solution dedicated to Advertising & Promotional Review.
-
Our team of experts are equipped to guide you through every step of any Inspection, especially Pre-Approval Inspections, due to the nature of their criticality.
-
120Water creates an easy, resident-friendly experience that takes the hassle out of compliance sampling for you. From easy-to-use kits and comprehensive collection support, to data collection and reporting, our team can lighten the load of your next monitoring period.
WHITE PAPERS AND CASE STUDIES
-
How A CDMO Gained 40%+ Efficiency By Generating Automated APQRs
Discover how a CDMO's mounting challenges with manual product quality review (PQR) processes were resolved through the implementation of a next-generation cloud-based solution.
-
eSource Purpose Is Not Just To Complete The EDC
Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
Phase 1 Clinical Trial Designs And Strategies
With tailored guidance, sponsors can align their modern model-based and model-assisted design choices to program goals, accelerating progress while safeguarding patients.
-
How To Manage A Drug Product In A Medical Device Environment
Discover how ProPharma successfully ensured GMP and GDP compliance for a drug product within a medical device environment.
-
Reducing Risk And Timelines In Cell Line Development
Accelerate your biologic development by adopting faster, more reliable clone selection methods that reduce time and resources while improving the likelihood of identifying stable, high-producing cell lines.
-
The Benefits Of End-To-End Formulation And Fill/Finish Of Biologics
Proper formulation development has a huge impact on whether a technology transfer to clinical phase fill/finish is successful. Review the challenges of transitioning a promising drug candidate.
-
Thales Receives Custom 10PW Beam Dump For World's Most Powerful Laser
By collaborating with Gentec-EO and their distributor Laser Components, see how Thales was able to gather the necessary specifications and requirements for this project.
-
What Does The New FDA DHT Guidance Mean?
In December 2023, the FDA released the final version of its digital health technologies guidance, outlining the facilitated use of sensor-based DHTs and wearables in clinical investigations.
-
Solving The Silicone Challenge In Pre-Fillable Syringes
Discover a technology platform that is revolutionizing the pre-fillable syringe market by solving the challenge of silicone sensitivity, ensuring stability for sensitive drugs.
-
Clinical Trial Starts Rose At Slower Pace In 2024
Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.
-
Stopper Migration In Frozen Pre-Filled Syringes
Review a semi-automated method for dynamically assessing plunger migration under controlled variations in temperature and pressure, utilizing computer vision tools.
-
The Latest Trends In The Prevention And Treatment Of Cervical Cancer
What immune checkpoint inhibitors are showing promise in cervical cancer treatments and how are advancements in treatment, paired with additional prevention strategies, improving patient outcomes?
NEWS
-
Cleanfarms And TNRD Launch Agricultural Plastics Recycling Pilot Program10/8/2025
Cleanfarms and the Thompson-Nicola Regional District (TNRD) are launching a new pilot program to recycle bale wrap and silage bags and covers.
-
FAU Tells 'Story' Of Atlantic's Sargassum Surge Using 40 Years Of Data8/28/2025
Researchers at Florida Atlantic University’s Harbor Branch Oceanographic Institute have released a landmark review tracing four decades of changes in pelagic sargassum – free-floating brown seaweed that plays a vital role in the Atlantic Ocean ecosystem.
-
Merck To Acquire US Biopharma Company SpringWorks Therapeutics To Accelerate Sustainable Growth Of Healthcare Business4/28/2025
Merck, a leading science and technology company, and SpringWorks Therapeutics, Inc., a Stamford, Connecticut-based commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced the companies have entered into a definitive agreement for Merck to acquire SpringWorks.
-
Egetis Therapeutics Initiates New Drug Application In The USA For Emcitate (Tiratricol) For MCT8 Deficiency12/19/2025
Egetis Therapeutics AB (publ) (“Egetis” or the “Company”), today announced that the Company has initiated a rolling New Drug Application (NDA) submission to the U.S. Food and Drug Administration (FDA) for Emcitate (tiratricol), its investigational drug for the treatment of MCT8 deficiency.
-
Energy Department Slashes 47 Burdensome And Costly Regulations, Delivering First Milestone In America's Biggest Deregulatory Effort5/12/2025
The U.S. Department of Energy (DOE) today announced the first step in the Energy Department’s largest deregulatory effort in history, proposing the elimination or reduction of 47 regulations that are driving up costs and lowering quality of life for the American people.